Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

Bioavailability of vascular endothelial growth factor (VEGF)? A role in pulmonary fibrosis?

Shaney Barratt, Caroline Jarrett, Gavin Welsh, David Bates, Ann Millar
European Respiratory Journal 2012 40: P3752; DOI:
Shaney Barratt
1Lung Research Group, University of Bristol, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Caroline Jarrett
1Lung Research Group, University of Bristol, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gavin Welsh
1Lung Research Group, University of Bristol, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Bates
2Microvascular Research Laboratories, University of Bristol, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ann Millar
1Lung Research Group, University of Bristol, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Vascular endothelial growth factor (VEGF) is both a growth factor and permeability factor, involved in tissue repair and as such, has been proposed to have a role in the pathogenesis of pulmonary fibrosis. VEGF is generated as multiple isoforms of two families, VEGFxxx and VEGFxxxb and mediates its effects through specific receptors, VEGFR-1 and VEGFR-2 and co-receptors, neuropilin-1 and neuropilin-2. We hypothesised that these receptors, co-receptors and isoforms would be differentially expressed in normal versus fibrotic fibroblasts.

Normal fibroblasts (NF) and fibrotic fibroblasts (FF) (from patients with proven UIP) were extracted from lung samples using the explant method. Expression of VEGFR-1, 2 and NRP1-1, NRP2 and VEGF isoforms was established at the protein level using western blotting whilst receptor expression was confirmed with immunofluorescence staining of cells in culture.

Both NF and FF expressed VEGFR1 and 2, NRP-1 and 2 and VEGFxxx/xxxb isoforms. No significant differences in VEGFR-2 and NRP-1 expression between NF and FF fibroblast were detected, however both VEGFR-1 and NRP-2 were significantly reduced in FF versus NF (p<0.05, non-paired t-test).

VEGF receptors, co-receptors and isoforms are expressed differentially in NF and FF. This suggests a potential role for changes in VEGF bioactivity in the development of pulmonary fibrosis.

  • Cell biology
  • Interstitial lung disease
  • Lung injury
  • © 2012 ERS
Previous
Back to top
Vol 40 Issue Suppl 56 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Bioavailability of vascular endothelial growth factor (VEGF)? A role in pulmonary fibrosis?
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Bioavailability of vascular endothelial growth factor (VEGF)? A role in pulmonary fibrosis?
Shaney Barratt, Caroline Jarrett, Gavin Welsh, David Bates, Ann Millar
European Respiratory Journal Sep 2012, 40 (Suppl 56) P3752;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Bioavailability of vascular endothelial growth factor (VEGF)? A role in pulmonary fibrosis?
Shaney Barratt, Caroline Jarrett, Gavin Welsh, David Bates, Ann Millar
European Respiratory Journal Sep 2012, 40 (Suppl 56) P3752;
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Prostacyclin and VEGF in the rejection process after lung transplantation – A possible biomarker
  • Galectin-9 attenuates elastase-induced emphysema by reducing neutrophil chemotaxis in mice
  • Refinement of the hyperoxia-based experimental mouse model of bronchopulmonary dysplasia
Show more 3.3 Mechanisms of Lung Injury and Repair

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society